Literature DB >> 9328885

Multisensory speech perception of young children with profound hearing loss.

L Kishon-Rabin1, N Haras, M Bergman.   

Abstract

The contribution of a two-channel vibrotactile aid (Trill VTA 2/3, AVR Communications LTD) to the audiovisual perception of speech was evaluated in four young children with profound hearing loss using words and speech pattern contrasts. An intensive, hierarchical, and systematic training program was provided. The results show that the addition of the tactile (T) modality to the auditory and visual (A+V) modalities enhanced speech perception performance significantly on all tests. Specifically, at the end of the training sessions, the tactile supplementation increased word recognition scores in a 44-word, closed-set task by 12 percentage points; detection of consonant in final position by 50 percentage points; detection of sibilant in final position by 30 percentage points; and detection of voicing in final position by 25 percentage points. Significant learning over time was evident for all test materials, in all modalities. As expected, fastest learning (i.e., smallest time constants) was found for the AVT condition. The results of this study provide further evidence that sensory information provided by the tactile modality can enhance speech perception in young children.

Entities:  

Mesh:

Year:  1997        PMID: 9328885     DOI: 10.1044/jslhr.4005.1135

Source DB:  PubMed          Journal:  J Speech Lang Hear Res        ISSN: 1092-4388            Impact factor:   2.297


  2 in total

1.  Early listening and speaking skills predict later reading proficiency in pediatric cochlear implant users.

Authors:  Linda J Spencer; Jacob J Oleson
Journal:  Ear Hear       Date:  2008-04       Impact factor: 3.570

2.  Teaching Children With Hearing Loss to Recognize Speech: Gains Made With Computer-Based Auditory and/or Speechreading Training.

Authors:  Nancy Tye-Murray; Brent Spehar; Mitchell Sommers; Elizabeth Mauzé; Joe Barcroft; Heather Grantham
Journal:  Ear Hear       Date:  2022 Jan/Feb       Impact factor: 3.562

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.